Literature DB >> 8139701

Turning behavior induced by intrastriatal injection of neurotensin in mice: sensitivity to non-peptide neurotensin antagonists.

M Poncelet1, C Gueudet, D Gully, P Soubrié, G Le Fur.   

Abstract

The intrastriatal injection of neurotensin (10 pg/mouse) elicited vigorous contralateral rotations which were not affected by disruption of dopaminergic transmission using 6-OHDA lesion of the striatum or systemic administration of spiroperidol (0.03 mg/kg). SR 48692, a selective non-peptide antagonist of neurotensin receptor, produced the following pattern of changes: a significant antagonism of rotations was observed at 0.04 and 0.08 mg/kg i.p. followed by a reinstatement of rotations at 0.16-0.64 mg/kg (at higher doses, a second antagonism occurred that lacked stereoselectivity). The reinstatement of rotations observed at 0.16 and 0.32 mg/kg of SR 48692 was abolished by spiroperidol and 6-OHDA lesions, suggesting the role of dopamine regulatory mechanisms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8139701     DOI: 10.1007/bf00178206

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  18 in total

Review 1.  The neurobiology of neurotensin: focus on neurotensin-dopamine interactions.

Authors:  J Kasckow; C B Nemeroff
Journal:  Regul Pept       Date:  1991-10-29

2.  Evidence for dopaminomimetic effect of intrastriatally injected cholecystokinin octapeptide in mice.

Authors:  P Worms; J Martinez; C Briet; B Castro; K Biziere
Journal:  Eur J Pharmacol       Date:  1986-03-04       Impact factor: 4.432

3.  Neurotensin facilitates dopamine release in vitro from rat striatal slices.

Authors:  M E de Quidt; P C Emson
Journal:  Brain Res       Date:  1983-09-12       Impact factor: 3.252

4.  Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants.

Authors:  P F Von Voigtlander; K E Moore
Journal:  Neuropharmacology       Date:  1973-05       Impact factor: 5.250

5.  Regulation of neurotensin-containing neurons in the rat striatum. Effects of unilateral striatal lesions with quinolinic acid and ibotenic acid on neurotensin content and its binding site density.

Authors:  Y Masuo; M N Montagne; D Pélaprat; D Scherman; W Rostène
Journal:  Brain Res       Date:  1990-06-18       Impact factor: 3.252

6.  Neurotensin regulation of endogenous acetylcholine release from rat cerebral cortex: effect of quinolinic acid lesions of the basal forebrain.

Authors:  P A Lapchak; D M Araujo; R Quirion; A Beaudet
Journal:  J Neurochem       Date:  1990-10       Impact factor: 5.372

7.  Opposite effects of neurotensin on dopamine inhibition in different regions of the rat brain: an iontophoretic study.

Authors:  M Beauregard; A Ferron; L Descarries
Journal:  Neuroscience       Date:  1992       Impact factor: 3.590

8.  Neuropharmacological profile of a novel and selective ligand of the sigma site: SR 31742A.

Authors:  M Poncelet; V Santucci; R Paul; C Gueudet; S Lavastre; J Guitard; R Steinberg; J P Terranova; J C Brelière; P Soubrié
Journal:  Neuropharmacology       Date:  1993-06       Impact factor: 5.250

9.  Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing.

Authors:  P W Kalivas; C B Nemeroff; A J Prange
Journal:  Neuroscience       Date:  1984-04       Impact factor: 3.590

10.  Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.

Authors:  D Gully; M Canton; R Boigegrain; F Jeanjean; J C Molimard; M Poncelet; C Gueudet; M Heaulme; R Leyris; A Brouard
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

View more
  2 in total

Review 1.  Neurotensin receptors: binding properties, transduction pathways, and structure.

Authors:  J P Vincent
Journal:  Cell Mol Neurobiol       Date:  1995-10       Impact factor: 5.046

2.  Effects of SR 48692, a selective non-peptide neurotensin receptor antagonist, on two dopamine-dependent behavioural responses in mice and rats.

Authors:  M Poncelet; J Souilhac; C Gueudet; J P Terranova; D Gully; G Le Fur; P Soubrié
Journal:  Psychopharmacology (Berl)       Date:  1994-10       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.